Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             172 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bright spinal cord Lescroart, M.
1-2 p. 154-156
 artikel
2 A case of thoracic actinomycosis presenting as sudden paraplegia Peiffer-Smadja, N.
 2019
 1-2 p. 89-92
 artikel
3 Acknowledgements 2018
 1-2 p. iv
 artikel
4 Acknowledgements 2019
 1-2 p. iii-iv
 artikel
5 Acknowledgements
1-2 p. 1-2
 artikel
6 Acknowledgements
1-2 p. 1-2
 artikel
7 Acknowledgements
1-2 p. iii-iv
 artikel
8 Acknowledgements
1-2 p. 1-2
 artikel
9 A clinical and neurophysiological motor signature of Unverricht–Lundborg disease Hainque, E.
 2018
 1-2 p. 56-65
 artikel
10 A confused young woman Demas, A.
1-2 p. 143-144
 artikel
11 Acute and Post-Traumatic Stress Disorders: A biased nervous system Allene, C.
1-2 p. 23-38
 artikel
12 Acute brachial plexus lesion complicating a stun-gun assault Bonnan, M.
 2019
 1-2 p. 87-88
 artikel
13 Acute dysautonomia and erythromelalgia associated with testicular seminoma: A case report Demuth, S.
1-2 p. 146-147
 artikel
14 Acute ischemic stroke revealing late-onset glycogen storage disease Aissi, M.
 2017
 1-2 p. 75-77
3 p.
 artikel
15 ADAM10 as a biomarker for Alzheimer's disease: A systematic review Oliveira Monteiro e Pereira de Almeida, M.P.
1-2 p. 1-11
 artikel
16 Address from the previous President, January 2017 Delattre, J.-Y.
 2017
 1-2 p. 2-3
2 p.
 artikel
17 Adress from the President, January 2017 Edan, G.
 2017
 1-2 p. 4-5
2 p.
 artikel
18 A first case of Mild Encephalitis with Reversible Splenial Lesion(MERS) as a presenting feature of SARS-CoV-2 EL Aoud, S.
1-2 p. 139-141
 artikel
19 All that glitters is not gold: A limbic encephalitis due to neurosyphilis Pisché, G.
1-2 p. 156-157
 artikel
20 Anatomy and physiology of the autonomic nervous system: Implication on the choice of diagnostic/monitoring tools in 2023 Roche, F.
1-2 p. 42-52
 artikel
21 An educational case series of Parkinson's disease during the COVID-19 pandemic Lo Monaco, M.R.
1-2 p. 134-136
 artikel
22 A novel KIF5a mutation identified in two-family members with spastic paraplegia type 10 Oliveira, R.
1-2 p. 152-154
 artikel
23 An overview on pure autonomic failure Pavy-Le Traon, A.
1-2 p. 94-100
 artikel
24 An update on epidemiology, diagnosis & management of NMO-SD in the tertiary neurology department of Marrakech (Morocco) Kissani, N.
1-2 p. 80-84
 artikel
25 Arterial ischemic stroke in non-neonate children: Diagnostic and therapeutic specificities Kossorotoff, M.
1-2 p. 20-29
 artikel
26 A single case of tics secondary to gunshot wound Daubigney, A.
1-2 p. 151-152
 artikel
27 Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes Villagrán-García, M.
1-2 p. 107-116
 artikel
28 Benign syndrome of transient epileptic amnesia: Good outcome after 67 years of follow-up Cretin, B.
1-2 p. 124-125
 artikel
29 Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach Rayess, Y.A.
1-2 p. 107-114
 artikel
30 Brain molecular imaging in pharmacoresistant focal epilepsy: Current practice and perspectives Verger, A.
 2018
 1-2 p. 16-27
 artikel
31 Can we discontinue disease-modifying treatments in multiple sclerosis patients? Comments Gouider, R.
 2017
 1-2 p. 44-46
3 p.
 artikel
32 Can we discontinue disease-modifying treatments in multiple sclerosis patients? No Papeix, C.
 2017
 1-2 p. 41-43
3 p.
 artikel
33 Can we discontinue disease-modifying treatments in multiple sclerosis patients? Yes Laplaud, David
 2017
 1-2 p. 38-40
3 p.
 artikel
34 Capnocytophaga canimorsus, a rare cause of bacterial meningitis Beltramone, M.
 2017
 1-2 p. 74-75
2 p.
 artikel
35 Causality and complex disease: The example of multiple sclerosis Bach, J.-F.
 2018
 1-2 p. 2-3
 artikel
36 Central pontine myelinolysis in a type 1 diabetes patient with chronic hepatitis Gourine, M.
 2018
 1-2 p. 66-67
 artikel
37 Cerebral fat embolism after autologous fat injection for reconstructive eye surgery Renard, D.
 2019
 1-2 p. 94-95
 artikel
38 Cerebral ischaemia with unknown onset: Outcome after recanalization procedure Tortuyaux, R.
1-2 p. 75-84
 artikel
39 Chronic lymphocytic leukemia with central nervous system infiltration versus CLL-associated auto-immune disease with neurological involvement: A tricky differential diagnosis Peter, E.
1-2 p. 120-123
 artikel
40 Clinical efficacy of tacrolimus for treating myasthenia gravis and its influence on lymphocyte subsets Bao, J.
 2019
 1-2 p. 65-72
 artikel
41 Clinical features of pain in amyotrophic lateral sclerosis: A clinical challenge Delpont, B.
 2019
 1-2 p. 11-15
 artikel
42 Clinicoradiological and prognostic features of COVID-19-associated acute disseminated encephalomyelitis Oumerzouk, J.
1-2 p. 144-150
 artikel
43 CONFISEP: Impact of the Covid-19 pandemic lockdown on patients with multiple sclerosis in the north of France Donzé, C.
1-2 p. 151-155
 artikel
44 Contents
1-2 p. iv-v
 artikel
45 Contents
1-2 p. v-vi
 artikel
46 Contents
1-2 p. iv-v
 artikel
47 Contrast enhanced ultrasound of carotid plaque in acute ischemic stroke (CUSCAS study) Baud, J.M.
1-2 p. 115-123
 artikel
48 Contribution of muscle MRI for diagnosis of myopathy Venturelli, N.
1-2 p. 61-80
 artikel
49 COVID-19: A putative trigger for neuralgic amyotrophy Balloy, G.
1-2 p. 157-158
 artikel
50 Crosschecking the subjective everyday Parkinson's experience among patients and their caregiving spouses: French versions of the Belastungsfragebogen Parkinson Kurzversion (Bela-P-k and Bela-A-k) Bayen, S.
1-2 p. 24-32
 artikel
51 Current treatments of spinal muscular atrophy in adults Cintas, P.
1-2 p. 106-113
 artikel
52 Delayed awakening in neurocritical care Bouchereau, E.
1-2 p. 21-33
 artikel
53 “De-novo” consultation: Evaluation of an outpatient's clinic dedicated to early diagnosis of parkinsonian syndromes Ruggeri, J.
 2017
 1-2 p. 55-61
7 p.
 artikel
54 Diagnosing SARS-CoV-2 vaccination associated aseptic meningitis is intricate Finsterer, J.
1-2 p. 156-157
 artikel
55 Dystonia of the soft palate: Mutation of the THAP1 (DYT6) gene in a 42-year-old patient Grimaldi, S.
 2018
 1-2 p. 67-68
 artikel
56 Editorial Azulay, J.-P.
 2017
 1-2 p. 1-
1 p.
 artikel
57 Editorial Dauvilliers, Y.
 2017
 1-2 p. 6-7
2 p.
 artikel
58 Editorial Azulay, J.-P.
 2018
 1-2 p. 1
 artikel
59 Editorial Azulay, J.-P.
 2019
 1-2 p. 1
 artikel
60 Editorial Azulay, J.-P.
1-2 p. 3
 artikel
61 Editorial Couratier, P.
1-2 p. 4
 artikel
62 Editorial Board 2017
 1-2 p. i-
1 p.
 artikel
63 Editorial Board 2018
 1-2 p. i
 artikel
64 Editorial Board 2019
 1-2 p. i
 artikel
65 Editorial Board
1-2 p. i
 artikel
66 Editorial Board
1-2 p. i
 artikel
67 Editorial Board
1-2 p. i
 artikel
68 Editorial Board
1-2 p. i
 artikel
69 Editorial Board
1-2 p. i
 artikel
70 Electrophysiology in diagnosis and management of neuropathic pain Garcia-Larrea, L.
 2019
 1-2 p. 26-37
 artikel
71 Entrapment partly participates in the longitudinal progression of neuropathy with anti-MAG antibodies Ohara, M.
1-2 p. 118-122
 artikel
72 Erratum to “Brain connectivity and auditory hallucinations: In search of novel noninvasive brain stimulation therapeutic approaches for schizophrenia” [Rev. Neurol. 159 (11) (2016)] Thomas, F.
 2017
 1-2 p. 79-
1 p.
 artikel
73 Erratum to « Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review » [Rev. Neurol. 173 (5) (2017) 300–307] Danel-Brunaud, V.
 2018
 1-2 p. 75
 artikel
74 Ethical issues in neurocritical care Perrigault, P.F.
1-2 p. 57-63
 artikel
75 Factors associated with patent foramen ovale-related stroke: SAFAS study Pommier, T.
1-2 p. 33-41
 artikel
76 Factors influencing time between onset of signs/symptoms and referral for dementia in elderly outpatients Koskas, P.
 2018
 1-2 p. 36-43
 artikel
77 First-ever treatment in multiple sclerosis Pantazou, V.
1-2 p. 93-99
 artikel
78 French consensus. Hypersomnolence: Evaluation and diagnosis Dauvilliers, Y.
 2017
 1-2 p. 19-24
6 p.
 artikel
79 French consensus. Idiopathic hypersomnia: Investigations and follow-up Leu-Semenescu, S.
 2017
 1-2 p. 32-37
6 p.
 artikel
80 French consensus. Management of patients with hypersomnia: Which strategy? Lopez, R.
 2017
 1-2 p. 8-18
11 p.
 artikel
81 French consensus. Type 1 and type 2 Narcolepsy: Investigations and follow-up Monaca, C.
 2017
 1-2 p. 25-31
7 p.
 artikel
82 French validation of the Brief International Cognitive Assessment for Multiple Sclerosis Maubeuge, N.
1-2 p. 73-79
 artikel
83 Froin's syndrome dissemination from temporal horn entrapment after stereotactic needle biopsy Sánchez Carteyron, A.
1-2 p. 128-129
 artikel
84 Functional imaging of pain Peyron, R.
 2019
 1-2 p. 38-45
 artikel
85 Fungous tumour in the dura mater, first description of meningioma by the surgeon Antoine Louis (1723–1792) Walusinski, O.
1-2 p. 117-123
 artikel
86 Gene therapy review: Duchenne muscular dystrophy case study Berling, E.
1-2 p. 90-105
 artikel
87 Genetics of neonatal onset epilepsies: An overview Milh, M.
1-2 p. 2-9
 artikel
88 Georges Serratrice Pouget, J.
1-2 p. 3-6
 artikel
89 Guillain–Barré syndrome due to hepatitis E Troussière, A.C.
 2018
 1-2 p. 72-74
 artikel
90 Guillain–Barré syndrome subtypes: A clinical electrophysiological study of 100 patients Grapperon, A.-M.
 2019
 1-2 p. 73-80
 artikel
91 Health characteristics and health care trajectory of polyhandicaped person before and after 1990 Rousseau, M.-C.
1-2 p. 92-99
 artikel
92 Homage to a monumental figure of neurology Askenasy, J.
 2018
 1-2 p. 13-15
 artikel
93 Identification and measurement of cervical spinal cord atrophy in neuromyelitis optica spectrum disorders (NMOSD) and correlation with clinical characteristics and cervical spinal cord MRI data Lersy, F.
1-2 p. 85-92
 artikel
94 Immunomodulation in the acute phase of autoimmune encephalitis Ciano-Petersen, N.L.
1-2 p. 34-47
 artikel
95 Impairment in oral medical comprehension in multiple sclerosis Ehrlé, N.
1-2 p. 65-72
 artikel
96 Intensive care management of patients with viral encephalitis Sonneville, R.
1-2 p. 48-56
 artikel
97 Intensive care unit-acquired weakness: Questions the clinician should ask Tortuyaux, R.
1-2 p. 84-92
 artikel
98 Intracerebral haemorrhage, microbleeds and antithrombotic drugs Casolla, B.
1-2 p. 11-22
 artikel
99 Ischemic cerebrovascular diseases in patients with COVID-19 El Aoud, S.
1-2 p. 136-139
 artikel
100 Ischemic stroke and demyelinating lesion in a radiologically isolated syndrome Sánchez Carteyron, A.
1-2 p. 126-127
 artikel
101 Is paralysis necessarily a neurological disorder? A case of life-threatening tetraparesis Tortuyaux, R.
 2019
 1-2 p. 92-94
 artikel
102 Is the Choosing Wisely® campaign model applicable to the management of multiple sclerosis in France? A GRESEP pilot study Trumbic, B.
 2018
 1-2 p. 28-35
 artikel
103 Jean-Charles Chatelin (1884–1948), counted among the “Righteous”, but forgotten as a neurologist who studied under Pierre Marie Walusinski, O.
1-2 p. 43-52
 artikel
104 Joseph Jumentié (1879–1928), a forgotten neurologist Walusinski, O.
 2018
 1-2 p. 4-12
 artikel
105 Large brain cavitation revealing neuromyelitis optica. Neuroimage Bonnan, M.
1-2 p. 125-126
 artikel
106 Leukodystrophies and genetic leukoencephalopathies in children Sarret, C.
1-2 p. 10-19
 artikel
107 Liste des membres (2016) 2017
 1-2 p. 80-100
21 p.
 artikel
108 Liste des membres (2017) 2018
 1-2 p. 76-96
 artikel
109 Liste des membres (2018) 2019
 1-2 p. 98-118
 artikel
110 Locked-in syndrome following meningitis with brainstem abscess Mathais, Q.
 2019
 1-2 p. 88-89
 artikel
111 Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients Chaumont, H.
1-2 p. 137-143
 artikel
112 Management of lower urinary tract symptoms in Parkinsonian disorders Guillot-Tantay, C.
1-2 p. 101-106
 artikel
113 Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement Bordet, Régis
1-2 p. 100-112
 artikel
114 Monuments to Cajal in Madrid, Spain: Rejection of public tributes Giménez Roldan, S.
 2019
 1-2 p. 2-10
 artikel
115 MRI characteristics of MOG-Ab associated disease in adults: An update Shor, N.
1-2 p. 39-50
 artikel
116 Neurocritical care for neurological incapacitated patients Ben Hadj Salem, O.
1-2 p. 105-110
 artikel
117 Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians Maury, A.
1-2 p. 51-64
 artikel
118 Neuropathic pain: Definition, assessment and epidemiology Bouhassira, D.
 2019
 1-2 p. 16-25
 artikel
119 Newer anti-epileptic drugs, vitamin status and neuropathy: A cross-sectional analysis Cahill, V.
 2017
 1-2 p. 62-66
5 p.
 artikel
120 New onset refractory status epilepticus: State of the art Périn, B.
1-2 p. 74-83
 artikel
121 Non pharmacological treatment for neuropathic pain: Invasive and non-invasive cortical stimulation Moisset, X.
 2019
 1-2 p. 51-58
 artikel
122 Orthostatic hypotension: Review and expert position statement Vidal-Petiot, E.
1-2 p. 53-64
 artikel
123 O'Sullivan–McLeod syndrome: Unmasking a rare atypical motor neuron disease Pinto, W.B.V.R.
 2019
 1-2 p. 81-86
 artikel
124 Parvovirus B19-related peripheral nerve necrotizing vasculitis following SARS-CoV-2 infection Fargeot, G.
1-2 p. 158-160
 artikel
125 Pediatric onset multiple sclerosis Deiva, K.
1-2 p. 30-36
 artikel
126 Pharmacological treatments of neuropathic pain: The latest recommendations Attal, N.
 2019
 1-2 p. 46-50
 artikel
127 Please help me Salamat, E.
1-2 p. 150-151
 artikel
128 Post-herpetic anti-N-methyl-d-aspartate receptor encephalitis in a pregnant woman Tailland, M.
1-2 p. 129-131
 artikel
129 Postictal syndrome: The forgotten continent. An overview of the clinical, biochemical and imaging features Doudoux, H.
1-2 p. 62-74
 artikel
130 Post infectious encephalitis at Covid19: About one pediatric observation and review of the literature Kahwagi, J.
1-2 p. 132-134
 artikel
131 Postinfectious longitudinal extensive myelopathy after hand-foot-and-mouth disease in an immunocompetent adult Baldé, A.O.M.
 2017
 1-2 p. 77-78
2 p.
 artikel
132 Post-stroke follow-up: Time to organize Santos, Etienne
 2019
 1-2 p. 59-64
 artikel
133 Pourfour du Petit (1664–1741) Pearce, J.M.S.
1-2 p. 7-10
 artikel
134 Progress in hereditary neuropathies, myopathies and motoneuron disorders! Camdessanché, J.-P.
1-2 p. 3-4
 artikel
135 Pseudotumoral cerebellitis with acute hydrocephalus as a manifestation of EBV infection Geurten, C.
 2018
 1-2 p. 70-72
 artikel
136 PSP-Richardson syndrome mimics: An overview and pragmatic approach Necpál, J.
1-2 p. 12-23
 artikel
137 Recurrent posterior reversible encephalopathy syndrome in a patient with acute intermittent porphyria Fourgeaud, M.
1-2 p. 118-120
 artikel
138 Relapse of acute lymphoblastic leukemia revealed by an optic neuropathy Jamoussi, H.
1-2 p. 131-136
 artikel
139 Reprint of : Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology Mas, Jean-Louis
1-2 p. 53-61
 artikel
140 Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening Sablot, D.
 2017
 1-2 p. 47-54
8 p.
 artikel
141 Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis Etemadifar, M.
1-2 p. 121-128
 artikel
142 Rosette-forming glioneuronal tumor: A case report Kusznir Vitturi, B.
1-2 p. 147-150
 artikel
143 Sensory motor ataxic neuropathy associated dysarthria and ophthalmoplegia “SMANDO” in a consanguineous Moroccan patient with new POLG gene homozygote mutation Rafai, M.A.
1-2 p. 144-146
 artikel
144 Serge Brion (1921–2021) Lechevalier, B.
1-2 p. 5-6
 artikel
145 Shaping the future of neurocritical care in France Rohaut, B.
1-2 p. 7-8
 artikel
146 Should we prevent thrombosis related to intravenous immunoglobulin infusions with systematic anticoagulant prophylaxis? Arcani, R.
1-2 p. 100-106
 artikel
147 SMART syndrome: Classic transient symptoms leading to an unusual unfavorable outcome Bompaire, F.
 2017
 1-2 p. 67-73
7 p.
 artikel
148 Steroid-responsive aseptic meningitis after BNT162b2 SARS-CoV-2 vaccine Reis Carneiro, D.
1-2 p. 160-161
 artikel
149 Strategy for genetic analysis in hereditary neuropathy Masingue, M.
1-2 p. 10-29
 artikel
150 Stroke symptoms impact on mental and physical health: A Lebanese population based study Bou Ali, I.
1-2 p. 124-131
 artikel
151 The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19 Fathi, M.
1-2 p. 129-136
 artikel
152 The etiology of nodding syndrome phenotypes remains unknown§,§§ Spencer, P.S.
1-2 p. 141-143
 artikel
153 The gut-brain axis in Parkinson's disease Bonaz, B.
1-2 p. 65-78
 artikel
154 The higher prevalence of multiple sclerosis among Iranian Georgians; new clues to the role of genetic factors Etemadifar, M.
1-2 p. 113-117
 artikel
155 The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage Balança, B.
1-2 p. 64-73
 artikel
156 The new horizons for treatment of Late-Onset Pompe Disease (LOPD) Guémy, C.
1-2 p. 81-89
 artikel
157 Therapeutic tools for familial ALS Camu, W.
1-2 p. 49-53
 artikel
158 Therapeutic tools for inherited neuropathies Péréon, Y.
1-2 p. 5-9
 artikel
159 The RAPID-II Neuropsychological Test battery for subjects aged 20 to 49 years: Norms and cognitive profile Binetruy, M.
 2018
 1-2 p. 44-55
 artikel
160 Toward a coherent structuration of disorders of consciousness expertise at a country scale: A proposal for France Naccache, L.
1-2 p. 9-20
 artikel
161 Toxic-metabolic encephalopathy in adults: Critical discussion and pragmatical diagnostic approach Le Guennec, L.
1-2 p. 93-104
 artikel
162 Transition from paediatric to adult care in adolescents with neurological diseases and handicap Chabrol, B.
1-2 p. 37-42
 artikel
163 Treating hereditary transthyretin amyloidosis: Present & future challenges Echaniz-Laguna, A.
1-2 p. 30-34
 artikel
164 Treatment of Charcot-Marie-Tooth neuropathies Beloribi-Djefaflia, S.
1-2 p. 35-48
 artikel
165 Treatment of hereditary amyotrophic lateral sclerosis Corcia, P.
1-2 p. 54-60
 artikel
166 Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment Clement, G.
1-2 p. 79-93
 artikel
167 Use of a high-fidelity patient simulator for training 200 medical students in seizure management: A pilot study at the PRESAGE simulation center in Lille Moreau, C.
 2018
 1-2 p. 68-70
 artikel
168 Use of CHADS2 and CHA2DS2-VASc scores to predict prognosis after stroke Kusznir Vitturi, B.
1-2 p. 85-91
 artikel
169 Varicella Zoster Virus vasculopathy in a patient treated with immune checkpoint inhibitor for lung cancer Ursu, R.
 2019
 1-2 p. 95-97
 artikel
170 Wasted leg syndrome: An atypical slowly-progressive form of lower motor neuron disease Schön, M.
1-2 p. 114-117
 artikel
171 Weaning from mechanical ventilation in neurocritical care Bureau, C.
1-2 p. 111-120
 artikel
172 What's next in Neuropediatrics in 2019 Chabrol, B.
1-2 p. 1
 artikel
                             172 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland